/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/2025-02-21-10-18-18-930-67b852ea9b36d362eabb1030.png)
The EPO Board of Appeal (“BoA”) recently rejected a patent application relating to pig-human chimeras, concluding that the invention was...
BioTalk
Powered by Bird & Bird
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/2025-02-19-14-57-10-864-67b5f146143d887bc4dda20b.png)
A recent EU directive will have significant consequences for Australian life sciences companies operating in Europe. Directive 2024/2853...
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/2025-02-14-09-07-01-744-67af07b54a695cb0139e3eb3.png)
A new European directive is set to significantly impact pharmaceutical companies operating within the European Union. Directive (EU)...
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/2025-02-10-14-10-03-022-67aa08bbac4eaafbfac7c819.png)
On 11 December 2024, the MHRA published an updated roadmap for the future of the regulatory framework for medical devices in the UK,...
/Passle/65b10a249576f7f0a5a2f163/MediaLibrary/Images/2024-10-15-07-08-25-298-670e14e9b3157324cf24ba0c.jpg)
* This article was co-authored with Olivia Zhao from Bird & Bird Lawjay Shanghai association team. On 3 January 2025, the General Office...